Graphnet partners with Greater Manchester on diagnostics innovation programme

A health innovation programme to advance the use of novel diagnostics across Greater Manchester has been boosted by over £6m investment from life sciences, digital and creative industry partners, as well as £7.7m from Innovate UK, the UK’s national innovation agency.

The £14m programme includes a range of projects in diagnosing liver disease, heart failure, lung cancer, chest pain and cardiometabolic conditions, as well as the ground-breaking DEVOTE programme, to deliver bedside genomic tests to prevent a second stroke in a patient who has experienced a stroke; rapid point of care devices to detect genetic changes; and the development of a ‘pharmacogenetic passport’ to improve the effectiveness and safety of medicines for patients.

The health innovation accelerator is delivered through a partnership between Health Innovation Manchester, Manchester University NHS Foundation Trust, and the University of Manchester.

Graphnet has worked closely with Greater Manchester since 2020, when the Greater Manchester Care Record (GMCR) was launched, powered by Graphnet’s CareCentric software. The record joins up care for 2.8 million residents by integrating information from over 500 organisations and is seen as a key digital enabler in the region’s provision of care. 

For the full story, visit healthinnovationmanchester.com/news/greater-manchester-diagnostics-innovation-programme-secures-over-14m-investment.